BioSystem Development Closes a Near $1 Million Investment Round

MADISON, Wis.--(BUSINESS WIRE)--BioSystem Development, a privately held life science analytics company, announces a recently completed investment round that raised $978,000 (USD) in funding. The proceeds will be used to expand manufacturing infrastructure and to launch new products into the biopharmaceutical development market. Founder and Chief Executive Officer Scott Fulton stated, “We are pleased to close the round. This funding provides us the means to respond to growing market interest and launch several new disruptive AssayMAP products.”